Morgan Lewis

Related News

06/06/12 Morgan Lewis Advises The Kraft Group and Schwarz Partners on International Paper Mill Acquisitions
Morgan Lewis represented The Kraft Group and Schwarz Partners JV on their acquisition of two containerboard mills from global paper and packaging company International Paper.
12/12/06 Morgan Lewis Attorneys Assist in Obtaining Patent for Subject Matter of Nobel Prize
Morgan Lewis attorneys represented the Carnegie Institution of Washington before the U.S. Patent & Trademark Office in obtaining U.S. Patent 6,506,559, which claims the subject matter awarded the Nobel Prize in Medicine for 2006.
View all news
Photo of  Robert Smyth, Ph.D.

practice accolades

Patent

Ranked, National Tier 1: Biotechnology Law by U.S. News and Best Lawyers (2010–2012)

honors + affiliations

Member, American Bar Association, Intellectual Property Section

Member, American Intellectual Property Law Association, Biotechnology Committee

Member, Intellectual Property Owners Association, International Patent Practice Committee

bar admissions

  • District of Columbia
  • Maryland

Court Admissions

  • U.S. Patent and Trademark Office
print profile

Robert Smyth, Ph.D.
Partner


Email: rsmyth@morganlewis.com
Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5139
Fax: 202.739.3001

Robert Smyth, Ph.D., is a partner in Morgan Lewis's Intellectual Property Practice. Dr. Smyth's practice focuses on all aspects of biotechnology and pharmaceutical patent prosecution (both domestic and foreign); opinions involving patent infringement, freedom to operate, and validity; pre-litigation analysis; due diligence analysis; and license agreements. His practice also focuses on intellectual property due diligence analysis associated with venture capital financing and public offerings.

Dr. Smyth also counsels biotechnology companies in the development and commercialization of therapeutic and diagnostic products. He has an extensive background in the areas of pharmacology, immunology, virology, and molecular biology. He also has published and has been an invited speaker on intellectual property issues facing the biotechnology industry. Prior to joining Morgan Lewis, he worked at a biotechnology company managing the prosecution and licensing of biotechnology and pharmaceutical patents and applications.

Dr. Smyth received his J.D. from Temple University, James E. Beasley School of Law. He also holds a Ph.D. in pharmacology from Temple University School of Medicine and a B.S. in biology from Syracuse University. In addition, Dr. Smyth completed his post-doctoral fellowship in virology at the University of Pennsylvania School of Medicine.

Dr. Smyth is admitted to practice in the District of Columbia and Maryland only and before the U.S. Patent and Trademark Office.

education

  • Temple University School of Law, 1999, J.D.
  • University of Pennsylvania, 1997, P.D.F. (Virology)
  • Temple University, 1995, Ph.D. (Pharmacology)
  • Syracuse University, 1989, B.S. (Biology)